Pulling SEC filings + quote and writing the call…
ENTA
ENANTA PHARMACEUTICALS INC
Next earnings Aug 10, 2026 · consensus $-0.46 EPS, $18.3M rev
Last earnings +0.8% on 2026-05-11
$12.62
▼ -0.16%$12.66▲ +73.90%
over 1Y
L $6.49EODHDH $16.85
Earnings Dividend Split Congress buy Congress sellFilings colored by tone · hover for detail
Today-0.2%
1W+10.0%
1M-8.0%
3M-2.6%
YTD-12.2%
1Y+73.9%
Avoid
Conviction
Horizon
Medium (3–12mo)
Street · 13 analysts
Buy
Revenue declined -3.4% YoY.
ENANTA PHARMACEUTICALS INC shows $65.3M in FY2025 revenue (-3.4% YoY), a -125.4% net margin, and -126.5% ROE.
Sources: SEC EDGAR (CIK 0001177648, latest 10-Q filed 2026-05-13) · EODHD · as of 6/22/2026, 12:31:32 PM.
Research and education only — not financial advice. Calls are generated from SEC filings and a delayed/third-party price feed, may be wrong or out of date, and are not a recommendation to buy or sell any security. Do your own research.